Carson Wealth (CWM LLC)
PYXS icon

Carson Wealth (CWM LLC)’s Pyxis Oncology PYXS Stock Holding History

Carson Wealth (CWM LLC)’s Portfolio PYXS Stock Details PYXS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$50 Sell
34
-36
-51% -$54 ﹤0.01% 5604
2025
Q4 		$0 Sell
70
-344
-83% -$1.21K ﹤0.01% 5587
2025
Q3 		$1K Sell
414
-6,122
-94% -$8.82K ﹤0.01% 5179
2025
Q2 		$7K Buy
6,536
+3,150
+93% +$3.55K ﹤0.01% 4483
2025
Q1 		$3K Buy
3,386
+3,140
+1,276% +$4.19K ﹤0.01% 4672
2024
Q4 		$0 Sell
246
-98
-28% -$283 ﹤0.01% 5107
2024
Q3 		$1K Buy
+344
New +$1.2K ﹤0.01% 4678
2023
Q4 		– Sell
-92
Closed – – 4447
2023
Q3 		$0 Hold
92
– – ﹤0.01% 4476
2023
Q2 		$0 Buy
+92
New +$292 ﹤0.01% 4412

Other funds holding PYXS

P
Pfizer New York $239M AUM 232.47% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
GGI
GordonMD Global Investments Beverely Hills, California $144M AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
HP
HealthInvest Partners Stockholm, Sweden $372M AUM 59.89% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Carson Wealth (CWM LLC)'s PYXS Position: Q1 2026 in Review

Carson Wealth (CWM LLC) reduced its Pyxis Oncology (PYXS) stake by 51% in Q1 2026, selling an estimated $54 and leaving 34 shares worth $50. The position accounts for ﹤0.01% of the portfolio, ranked #5604.

Carson Wealth (CWM LLC) first reported a position in PYXS in Q2 2023 and has held it in 9 quarters since. The position peaked at $7K in Q2 2025. 78 funds tracked by Wall St. Rank hold PYXS as of Q1 2026.

  • Carson Wealth (CWM LLC) held 34 shares of Pyxis Oncology worth $50 as of Q1 2026.
  • Carson Wealth (CWM LLC) sold 36 Pyxis Oncology shares in Q1 2026, an estimated $54.
  • Pyxis Oncology made up ﹤0.01% of Carson Wealth (CWM LLC)'s portfolio in Q1 2026, its #5604 holding.
  • Carson Wealth (CWM LLC) first reported a position in Pyxis Oncology in Q2 2023 and has held it in 9 quarters since.
  • Carson Wealth (CWM LLC)'s Pyxis Oncology position peaked at $7K in Q2 2025.
  • 78 funds tracked by Wall St. Rank held Pyxis Oncology as of Q1 2026.

Based on Carson Wealth (CWM LLC)'s 13F filing for Q1 2026, filed 14 May 2026.